DS
Therapeutic Areas
TargED Biopharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TGD001 | Immune Thrombotic Thrombocytopenic Purpura (iTTP) | Phase 1 |
Leadership Team at TargED Biopharmaceuticals
KV
Kristof Vercruysse
Chief Executive Officer
SD
Steven de Maat, PhD
Chief Scientific Officer
MV
Marc van Moorsel
Director of Operations
JH
Josi Holz
Chief Medical Officer
FV
Filip Van den Wyngaert
Vice President Asset Management
CM
Coen Maas, PhD
Scientific Co-Founder